Vertical Pharmaceuticals

What Vertical Pharmaceuticals does

Vertical Pharmaceuticals LLC is a privately held US specialty pharmaceutical company founded in 2003 and headquartered at 1880 McFarland Parkway, Alpharetta, Georgia. The company markets a branded portfolio of FDA-approved prescription and over-the-counter pharmaceutical products organized across three therapeutic categories: Women's Health (ObComplete prenatal nutrition, Corvite-FE iron supplement, Divigel menopausal symptom relief, Provella probiotic), Pain Management (CONZIP opioid analgesic, LORZONE musculoskeletal treatment), and Central Nervous System (Relexxii for ADHD, VEN-Brand antidepressant).

Its core technology is pharmaceutical formulation science, including novel drug delivery systems and once-daily dosage forms designed to improve medication compliance, particularly in CNS indications where adherence is a known challenge. The product descriptions emphasize proprietary formulation work and FDA-approved status rather than any software, digital, or AI-enabled component. Distribution is conducted exclusively within the United States, routed through an enterprise field-sales motion that targets physicians and healthcare providers who prescribe the medications; products are dispensed through licensed pharmacies.

The company generates revenue from sales of branded prescription and OTC pharmaceutical products through this US healthcare channel. Pricing is not publicly disclosed and is communicated through prescribing information documents and healthcare providers rather than direct channels. Vertical operates as a wholly-owned subsidiary of Alora Pharmaceuticals, having been acquired in 2021 as part of Alora's acquisition of Osmotica Pharmaceuticals (Vertical's parent since 2016), and benefits from the Alora family's shared contract research, development, and manufacturing capabilities.

Name

Vertical Pharmaceuticals

Legal name

Vertical Pharmaceuticals LLC

Website

http://www.verticalpharma.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

251–500 employees

Short description

Vertical Pharmaceuticals LLC is a US-based specialty pharmaceutical company that markets branded prescription and OTC products across women's health, pain management, and central nervous system indications, operating as a wholly-owned subsidiary of Alora Pharmaceuticals.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN)

akta.pro secondary industries

Neurology & Psychiatry (CNS) Pharmaceuticals (HLAIAAAF), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Prescription pharmaceuticals
• Women's health medications
• Pain management drugs
• ADHD treatment medications
• Antidepressant medications

Headquarters

HQ city

Bridgewater

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Prescription Pharmaceutical Products: Revenue generated from the sale of FDA-approved prescription medications across women's health, pain management, and central nervous system therapeutic categories. Products are distributed through healthcare providers and pharmacies via prescription.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Vertical Pharmaceuticals markets a branded portfolio of FDA-approved prescription and over-the-counter pharmaceutical products in three specialty therapeutic areas: Women's Health (prenatal nutrition, iron supplementation, menopausal symptom relief, probiotics), Pain Management (opioid analgesics and musculoskeletal treatments), and Central Nervous System conditions (ADHD and depression treatments). Products are distributed domestically in the United States through healthcare providers and licensed pharmacies via prescription.

Product overview

Vertical Pharmaceuticals is a pharmaceutical company offering a portfolio of branded prescription and over-the-counter products across three therapeutic areas: Women's Health (prenatal vitamins, iron supplements, menopausal relief, and probiotics), Pain Management (opioid analgesics and musculoskeletal treatments), and Central Nervous System (ADHD treatments and antidepressants). The products span from ObComplete prenatal nutrition and Corvite-FE iron supplements to Divigel menopausal relief and Provella probiotics within Women's Health; CONZIP and LORZONE for Pain Management; and Relexxii for ADHD and VEN-Brand Antidepressant for depression in the CNS category. The company operates as a subsidiary of Alora Pharmaceuticals, having been acquired in 2021 along with parent company Osmotica Pharmaceuticals.

Differentiator

Problem solved

Functional benefit

Brands

• ObComplete: Prenatal nutrition dietary supplement
• Corvite-FE
• Divigel
• Provella
• CONZIP
• LORZONE
• Relexxii
• VEN

Products and services

• ObComplete Prescription prenatal dietary supplement providing essential nutrition for pregnant women. Targeted at prenatal care patients through OB/GYN prescribers.
• Corvite-FE Iron supplement for the treatment of iron deficiency and iron deficiency anemia, targeted at women with iron deficiency.
• Divigel Topical gel medication for the relief of menopausal symptoms, targeted at women in menopausal transition.
• Provella Probiotic dietary supplement supporting women's digestive and vaginal health, targeted at women seeking probiotic support.
• CONZIP Opioid analgesic medication for the management of moderate to severe pain, targeted at patients with acute or chronic pain conditions.
• LORZONE Muscle relaxant medication for the treatment of musculoskeletal conditions and associated pain.
• Relexxii Once-daily FDA-approved ADHD treatment medication for attention deficit hyperactivity disorder, designed to encourage medication compliance.
• VEN-Brand Antidepressant FDA-approved antidepressant medication formulated in once-daily doses for the treatment of depression.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• Alora PharmaceuticalscoreOthers · 1 January 2021In 2021, Alora Pharmaceuticals acquired Osmotica Pharmaceuticals, including subsidiary Vertical Pharmaceuticals. This acquisition bolstered Alora's platform of generic and branded product lines and contributed to long-term growth of contract research, development, and manufacturing capabilities.
• Osmotica PharmaceuticalscoreOthers · 1 January 2016In 2016, Vertical Pharmaceuticals became a subsidiary of Osmotica Pharmaceuticals. This ownership structure provided Vertical with access to Osmotica's pharmaceutical development and manufacturing capabilities.

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• Upsher-Smith Laboratories: Upsher-Smith is a US specialty branded pharma with women's health, CNS, and pain products marketed through a specialty sales force. It mirrors Vertical's mid-sized specialty business model and therapeutic-area breadth.
• Noven Pharmaceuticals: Noven is a specialty pharma long focused on women's health and transdermal drug delivery, making it directly comparable to Vertical's women's-health portfolio and novel-formulation technology approach (e.g., Divigel).
• Amneal Pharmaceuticals: Amneal is a US-headquartered specialty and generics pharma with branded and complex generics across women's health, CNS, and pain—closely matching Vertical's therapeutic mix and sub-scale branded-specialty positioning.
• Collegium Pharmaceutical: Collegium is a US specialty pharma centered on Schedule II pain management, with products such as Xtampza ER and Nucynta. It is a direct comparable for Vertical's CONZIP opioid franchise and its specialty-pain commercial model.
• Endo Inc. Endo is a specialty pharma with a meaningful branded pain and generics portfolio, including historically significant opioid assets. Its commercial focus on differentiated branded pain directly mirrors Vertical's CONZIP positioning and physician-detail model.
• Assertio Holdings: Assertio (formerly Depomed) is a specialty pharma focused on pain and CNS, marketing branded products like Gralise, Cambia, and Zipsor. It competes head-on with Vertical's CONZIP/LORZONE pain franchise in the differentiated-branded-pain category.
• TherapeuticsMD: TherapeuticsMD is a US specialty pharma focused on women's health, with branded products across menopause (Bijuva), vaginal health, and prenatal nutrition. It is the closest pure-play comparable to Vertical's women's-health franchise and similar niche branded specialty model.

Broad incumbents

• Pfizer: Pfizer is a broad pharmaceutical incumbent with significant women's-health (Premarin franchise), CNS (Zoloft legacy, Prevnar depression collaborations), and pain adjacencies. It is a broader market reference for how Vertical's products compete against big-pharma scale.
• AbbVie: AbbVie is a global pharma incumbent with a major women's-health franchise (Lo Loestrin via Allergan) plus CNS therapies like Vraylar. It overlaps with Vertical's women's-health and CNS segments as a much larger competitor in the same end markets.
• Bayer (Healthcare): Bayer is a diversified pharma incumbent with a substantial women's-health franchise (Mirena, Yaz, Climara). It competes with Vertical's women's-health products in the same prescriber and patient segments from a much broader commercial base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vertical Pharmaceuticals